IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 224 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,662 | +88.1% | 585 | +191.0% | 0.00% | – |
| Q2 2023 | $1,415 | -1.9% | 201 | -14.8% | 0.00% | – |
| Q1 2023 | $1,442 | +2.6% | 236 | +7.3% | 0.00% | – |
| Q4 2022 | $1,406 | -71.9% | 220 | -59.0% | 0.00% | – |
| Q3 2022 | $5,000 | -16.7% | 536 | +5.1% | 0.00% | – |
| Q2 2022 | $6,000 | +50.0% | 510 | +97.7% | 0.00% | – |
| Q1 2022 | $4,000 | -66.7% | 258 | -60.5% | 0.00% | – |
| Q4 2021 | $12,000 | -29.4% | 653 | -5.4% | 0.00% | -100.0% |
| Q3 2021 | $17,000 | +88.9% | 690 | +93.8% | 0.00% | – |
| Q2 2021 | $9,000 | +200.0% | 356 | +350.6% | 0.00% | – |
| Q1 2021 | $3,000 | +50.0% | 79 | +75.6% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 45 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 45 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 45 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |